Some challenged claims of Data Health Partners Inc.'s patent that relates to a method and system for tracking goal progression are unpatentable as obvious over prior art, the Patent Trial and Appeal Board said, in an inter partes review by Teladoc Health Inc. The board determined that some challenged claims are obvious over various combinations of prior art, including prior art that relates to an electronic system and method for modifying therapeutic behavior, to a management interface for assigning patients to care providers, and to techniques for a software as a service provider to host a content analytics tool used ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.